Search results
Age-Related Macular Degeneration: Putting a Hole in Our World
WebMD· 19 hours agoWhen we’re young, we take our macula for granted. At the center of our retina – the deepest layer of the eye that’s chock-full of photoreceptors and that confers color to ...
CHOP restored eyesight for two children with one injection. It’s one more step for gene editing...
Philly.com· 5 days agoThe 10-year-old and 14-year-old patients had their eyesight improved about 10- to 100-fold after a...
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoApellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q1 2024 Earnings Call Transcript May 7, 2024 Apellis...
Q1 2024 Clearside Biomedical Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 17 hours agoIn March, we welcomed Dr. Victor Chong as our Chief Medical Officer. Victor is a well-respected board-certified retinal specialists with more than 25 years ...
What Is the Purpose of Fundus Photography?
MedicineNet.com· 16 hours agoFundus photography is the process of taking serial photographs of the interior of your eye through the pupil. A fundus camera is a specialized low-power microscope attached to a camera used ...
CHOP helps restore vision in 2 children using experimental gene editing treatment
CBS News· 5 days agoA first-of-its-kind genetic treatment at Children's Hospital of Philadelphia is restoring and...
Blessing-Rieman grad heading into career change
Quincy Herald-Whig· 3 days agoMason Alley says there’s a lot more to the radiologic sciences than many people think. “Research about the profession really sounds like all you’re doing...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 2 days agoISELIN, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of bevacizumab ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 4 days agoGenerated $172.3 million in 1Q 2024 revenues, including $163.1 million in U.S. net product sales $137.5 million for SYFOVRE® (pegcetacoplan injection) $25.6 million for EMPAVELI® (pegcetacoplan) Anticipates CHMP opinion for pegcetacoplan in GA
